Q&A: Benjamin Vandendriessche, Byteflies

Benjamin Vandendriessche shares his thoughts on what factors are limiting large-scale production of digital biomarkers and digital measurement tools, and how has digital medicine changed over the past two years.

Click Here to Download Your Copy